The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Alembic Pharmaceuticals successfully completes USFDA inspection for API-III facility
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
The European regulator will conduct a re-inspection of the facility to verify the compliance
Subscribe To Our Newsletter & Stay Updated